Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Egalet Corporation (NASDAQ: EGLT).

Full DD Report for EGLT

You must become a subscriber to view this report.


Recent News from (NASDAQ: EGLT)

FDA OKs first non-opioid treatment for opioid withdrawal
The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read ...
Source: SeekingAlpha
Date: May, 16 2018 16:44
Egalet's (EGLT) CEO Bob Radie on Q1 2018 Results - Earnings Call Transcript
Egalet Ltd. (EGLT) Q1 2018 Earnings Conference Call May 08, 2018 08:30 AM ET Executives Blair Clark-Schoeb - Senior Vice President of Communications Bob Radie - President and Chief Executive Officer Stan Musial - Chief Financial Officer Pat Shea - Chief Commercial Officer Mar...
Source: SeekingAlpha
Date: May, 09 2018 17:58
Egalet beats by $0.03, misses on revenue
Egalet (NASDAQ: EGLT ): Q1 EPS of -$0.26 beats by $0.03 . More news on: Egalet Ltd., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 06:03
Egalet Reports First Quarter 2018 Financial Results
WAYNE, Pa. , May 8, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today reported financial results for the first...
Source: PR Newswire
Date: May, 08 2018 06:02
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER
WAYNE, Pa. , May 7, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that a national pharmacy ...
Source: PR Newswire
Date: May, 07 2018 06:02
Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference
WAYNE, PA / ACCESSWIRE / May 2, 2018 / Egalet Corporation (NASDAQ: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that Bob Radie, Egalet's president ...
Source: ACCESSWIRE
Date: May, 02 2018 06:02
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse
WAYNE, Pa. , April 30, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced data on ARYMO ER (morphine ...
Source: PR Newswire
Date: April, 30 2018 06:02
Opioid prescriptions dropped 12% in 2017
Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 26 2018 03:18
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018
WAYNE, Pa. , April 24, 2018 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that its first quarter...
Source: PR Newswire
Date: April, 24 2018 06:02
Free Post Earnings Research Report: Egalet's Q4 Top-Line Growth Beat Estimates
Stock Monitor: Celsion Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 20, 2018 / Active-Investors.com has just released a free earnings report on Egalet Corp. (NASDAQ: EGLT ). If you want access to this report all you need to do is sign up now by clicking the following link w...
Source: ACCESSWIRE IA
Date: April, 20 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-220.500.50660.50980.49315,976
2018-05-210.530.49710.530.48391,723
2018-05-180.50380.5140.520.4951324,235
2018-05-170.530.49770.530.47521,054,831
2018-05-160.5650.4960.5740.4912,244,590

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2262,965132,95247.3592Short
2018-05-2161,867163,57437.8220Short
2018-05-1884,110175,24947.9946Short
2018-05-17246,899569,69043.3392Short
2018-05-16470,4611,089,30543.1891Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EGLT.


About Egalet Corporation (NASDAQ: EGLT)

Logo for Egalet Corporation (NASDAQ: EGLT)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $29,414,151 - 05/11/2018
  • Issue and Outstanding: 46,987,462 - 03/16/2018

 


Recent Filings from (NASDAQ: EGLT)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 02 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 05 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 23 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: March, 19 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 16 2018

 

 


Daily Technical Chart for (NASDAQ: EGLT)

Daily Technical Chart for (NASDAQ: EGLT)


Stay tuned for daily updates and more on (NASDAQ: EGLT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: EGLT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EGLT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of EGLT and does not buy, sell, or trade any shares of EGLT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/